Trial
NCT01094262
A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Collaborators
—
Condition
Osteoarthritis
Intervention
Oxycodone CR (standard pain medication)
Why stopped
Logistic reasons associated with the FDA-imposed clinical hold.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-11